NOVIMMUNE
LIVE

Serial Number

75907462

Owner

NovImmune SA

Attorney

Mark A. Jansen

Filing Date

Feb 1, 2000

Add to watchlist:

No watchlists yet
View on USPTO

NOVIMMUNE Trademark

Serial Number: 75907462 • Registration: 2873048

NOVIMMUNE is a trademark filed by NovImmune SA on February 1, 2000. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

NovImmune SA (6 trademarks)

15ch. Du Pré Fleuri, Plan les Ouates
Geneva 1228 , CH

Entity Type: 03

Trademark Details

Filing Date

February 1, 2000

Registration Date

August 17, 2004

Published for Opposition

February 24, 2004

Goods & Services

Pharmaceutical preparations used in humans and animals for the treatment of autoimmune diseases, inflammation and transplantation, namely, superantigens, small molecular weight compounds, polypeptides and monoclonal antibodies; pharmaceutical and veterinary preparations for the treatment of autoimmune diseases, inflammation and for use during transplantation, including diabetes, multiple sclerosis, rheumatoid arthritis and lupus, and for immuno-modulation, namely, immuno-suppression; pharmaceutical and veterinary preparations for the modulation and control of T lymphocyte activation; [ superantigens; superantigens encoded by human endogenous retroviruses; superantigens responsible for T cell activation in autoimmune diseases; regulatory factors responsible for the control of expression of MHC class II molecules, ] regulatory factors that are directly involved in the control of T lymphocyte activation; polypeptides to treat diseases; vaccines; monoclonal antibodies to treat diseases

Chemicals for use in the manufacture of pharmaceutical preparations used in humans and animals for the treatment of autoimmune diseases, inflammation and transplantation, including [ superantigens, ] small molecular weight compounds, polypeptides and monoclonal antibodies

legal services; scientific research; chemical research; consulting in the pharmaceutical and biomedical fields

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jul 16, 2025 NA89
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Jul 16, 2025 RNL2
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jul 16, 2025 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 15, 2025 APRE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 26, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 26, 2025 ECDR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
May 26, 2025 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 26, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 26, 2025 REAP
TEAS SECTION 8 & 9 RECEIVED
Feb 14, 2025 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Aug 17, 2023 REM2
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 20, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 20, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 20, 2023 ECDR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 20, 2023 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 20, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 20, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 20, 2023 COAR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 25, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 25, 2018 REAP
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jul 27, 2015 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jul 27, 2015 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jul 27, 2015 89AG
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Feb 18, 2015 EROP
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Sep 4, 2014 PR89
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 3, 2014 APRE
TEAS SECTION 8 & 9 RECEIVED
Aug 18, 2014 E89R
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Apr 22, 2011 8.OK
REGISTERED - SEC. 8 (6-YR) FILED
Apr 22, 2011 8.AF
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Mar 10, 2011 EROP
POST REGISTRATION ACTION MAILED - SEC. 8
Sep 10, 2010 PRA8
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 23, 2010 APRE
TEAS SECTION 8 RECEIVED
Aug 17, 2010 ES8R
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 17, 2010 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 17, 2010 COAR
EXPARTE APPEAL TERMINATED
Aug 24, 2004 EXPT
REGISTERED-PRINCIPAL REGISTER
Aug 17, 2004 R.PR
Sec. 1(B) CLAIM DELETED
Jun 30, 2004 1.BD
NOTICE OF ALLOWANCE CANCELLED
Jun 30, 2004 IUCN
PAPER RECEIVED
Jun 1, 2004 MAIL
NOA MAILED - SOU REQUIRED FROM APPLICANT
May 18, 2004 NOAM
PUBLISHED FOR OPPOSITION
Feb 24, 2004 PUBO
NOTICE OF PUBLICATION
Feb 4, 2004 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 5, 2003 CNSA
CASE FILE IN TICRS
Nov 13, 2003 CFIT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 14, 2003 CRFA
PAPER RECEIVED
Oct 14, 2003 MAIL
NON-FINAL ACTION MAILED
Apr 14, 2003 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 11, 2003 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 25, 2003 CNSA
ASSIGNED TO EXAMINER
Jan 27, 2003 DOCK
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 6, 2003 CRFA
PAPER RECEIVED
Jan 6, 2003 MAIL
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Oct 24, 2002 JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Oct 24, 2002 JURT
EXAMINERS STATEMENT MAILED
Jun 19, 2002 CNES
CONTINUATION OF FINAL REFUSAL MAILED
Nov 13, 2001 CNCF
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Oct 29, 2001 JURT
FINAL REFUSAL MAILED
Apr 6, 2001 CNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 27, 2000 CRFA
NON-FINAL ACTION MAILED
Jun 27, 2000 CNRT
ASSIGNED TO EXAMINER
Jun 21, 2000 DOCK
EX PARTE APPEAL-INSTITUTED
Oct 29, 1961 EXPI